1-20 of 167
transplantation
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.
https://doi.org/10.1182/hematology.2019000077
Published: 2019
Journal Articles

In MDS, is higher risk higher reward?

Guillermo F. Sanz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 381–390.
https://doi.org/10.1182/hematology.2019000042
Published: 2019
Journal Articles

MRD evaluation of AML in clinical practice: are we there yet?

Sylvie D. Freeman, Christopher S. Hourigan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 557–569.
https://doi.org/10.1182/hematology.2019000060
Published: 2019
Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.
https://doi.org/10.1182/hematology.2019000033
Published: 2019
Journal Articles

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Sung-Yun Pai
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 457–465.
https://doi.org/10.1182/hematology.2019000052
Published: 2019
Journal Articles

Evidence-Based Minireview: Does achieving MRD negativity after initial therapy improve prognosis for high-risk myeloma patients?

Surbhi Sidana, Elisabet Manasanch
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 142–147.
https://doi.org/10.1182/hematology.2019000075
Published: 2019
Journal Articles

Optimizing cord blood selection

Annalisa Ruggeri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 522–531.
https://doi.org/10.1182/hematology.2019000056
Published: 2019
Journal Articles

Monitoring and treatment of MDS in genetically susceptible persons

Stella M. Davies
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 105–109.
https://doi.org/10.1182/hematology.2019000020
Published: 2019
Journal Articles

We do still transplant CML, don’t we?

Charles F. Craddock
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 177–184.
https://doi.org/10.1182/asheducation-2018.1.177
Published: 2018
Journal Articles

Treatment approach for young, fit, newly diagnosed multiple myeloma patients

Saad Z. Usmani, Eric Seifter
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 97–102.
https://doi.org/10.1182/asheducation-2018.1.97
Published: 2018
Journal Articles

Alternative donor transplants for severe aplastic anemia

Andrea Bacigalupo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 467–473.
https://doi.org/10.1182/asheducation-2018.1.467
Published: 2018
Journal Articles

Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients

Sergio Giralt, Eric Seifter
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 103–109.
https://doi.org/10.1182/asheducation-2018.1.103
Published: 2018
Journal Articles

Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy

John Porter
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 361–370.
https://doi.org/10.1182/asheducation-2018.1.361
Published: 2018
Journal Articles

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Robert J. Soiffer, Yi-Bin Chen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 699–707.
https://doi.org/10.1182/asheducation-2017.1.699
Published: 2017
Journal Articles

Is molecular remission the goal of multiple myeloma therapy?

Faith E. Davies
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 205–211.
https://doi.org/10.1182/asheducation-2017.1.205
Published: 2017
Journal Articles

Fixed duration vs continuous therapy in multiple myeloma

Heinz Ludwig, Niklas Zojer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 212–222.
https://doi.org/10.1182/asheducation-2017.1.212
Published: 2017
Journal Articles

Treatment of inherited bone marrow failure syndromes beyond transplantation

Rodrigo T. Calado, Diego V. Clé
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 96–101.
https://doi.org/10.1182/asheducation-2017.1.96
Published: 2017
Journal Articles

Management of multiple myeloma in the newly diagnosed patient

María-Victoria Mateos, Jesús F. San Miguel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 498–507.
https://doi.org/10.1182/asheducation-2017.1.498
Published: 2017
Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.
https://doi.org/10.1182/asheducation-2017.1.708
Published: 2017
Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.
https://doi.org/10.1182/asheducation-2017.1.693
Published: 2017